| 注册
首页|期刊导航|中国药理学通报|MicroRNA与肿瘤铂类耐药的研究

MicroRNA与肿瘤铂类耐药的研究

魏小丽 顾康生 高梦如

中国药理学通报2017,Vol.33Issue(5):593-597,5.
中国药理学通报2017,Vol.33Issue(5):593-597,5.DOI:10.3969/j.issn.1001-1978.2017.05.001

MicroRNA与肿瘤铂类耐药的研究

Research of microRNAs and tumor platinum-resistance

魏小丽 1顾康生 1高梦如1

作者信息

  • 1. 安徽医科大学第一附属医院肿瘤内科,安徽 合肥 230032
  • 折叠

摘要

Abstract

Chemotherapy is one of the primary treatment for malignant tumors.Platinum drugs as the most commonly used cycle non-specific clinical antitumor drugs show good curative effect in the clinical treatment of solid tumors,however,resistance or cross-resistance of theplatinum analogous has become one of the main obstacles for platinum and its analogous,which limits their clinical applications.miRNAs play an important role in biology,including cell proliferation,differentiation,apoptosis,stress tolerance,and physiological metabolism.There is a close relationship between miRNAs target gene regulation and tumor drug-resistance.This article is mainly about the role of miRNAs in tumor of platinum resistance.

关键词

MicroRNA/抗肿瘤/肿瘤耐药/MDR/靶点/基因调控

Key words

microRNA/antitumor/chemo-resistance/MDR/targets/gene regulation

分类

医药卫生

引用本文复制引用

魏小丽,顾康生,高梦如..MicroRNA与肿瘤铂类耐药的研究[J].中国药理学通报,2017,33(5):593-597,5.

基金项目

安徽省对外科技合作计划项目(No1604b0602027) (No1604b0602027)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文